Vecuronium bromide 10mg/10mL; pwd for IV inj after reconstitution; contains benzyl alcohol, mannitol. <7wks: not recommended. Individualize. >7wks–10yrs: see literature. ≥10yrs: Relaxation for ...
SCHAUMBURG, Ill., Aug. 18, 2011 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT) today announced the launch of vecuronium bromide for injection, a neuromuscular blocking agent, in 10 and ...
Sagent Pharmaceuticals Inc has expanded a nationwide recall of vecuronium bromide for injection 10 mg, the US Food and Drug Administration (FDA) said today. Vecuronium bromide for injection is a ...
Vecuronium bromide 10mg/10mL; pwd for IV inj after reconstitution; contains benzyl alcohol, mannitol. <7wks: not recommended. Individualize. >7wks–10yrs: see literature. ≥10yrs: Relaxation for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback